Shanghai Bao Pharmaceuticals Co., Ltd.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 2019-12-16
- Employees
- -
- Market Cap
- -
- Website
- http://www.baopharma.com
A Clinical Trial with KJ103 in Anti-GBM Disease
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-23
- Last Posted Date
- 2024-09-23
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 12
- Registration Number
- NCT06607016
Hyaluronidase Assisted Subcutaneous Infusion
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2024-09-19
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 45
- Registration Number
- NCT06604546
- Locations
- 🇨🇳
Suzhou Municipal Hospital, Su Zhou, Jiangsu, China
A Study to Evaluate the Safety and Tolerability of KJ103 in Healthy Adults
- First Posted Date
- 2022-03-10
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Shanghai Bao Pharmaceuticals Co., Ltd.
- Target Recruit Count
- 34
- Registration Number
- NCT05274659
- Locations
- 🇳🇿
New Zealand Clinical Research, Auckland, New Zealand
© Copyright 2024. All Rights Reserved by MedPath